Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

New methodology reduces the data requirements for protein engineering by 99% so organizations can unlock innovation even in ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while ...